<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>541</ContextCount>
  <ElementCount>429</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>172</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>19</UnitCount>
  <MyReports>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00100 - Statement - Interim condensed consolidated statement of financial position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/StatementInterimCondensedConsolidatedStatementOfFinancialPosition</Role>
      <ShortName>Interim condensed consolidated statement of financial position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00200 - Statement - Interim condensed consolidated statement of income (loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/StatementInterimCondensedConsolidatedStatementOfIncomeLoss</Role>
      <ShortName>Interim condensed consolidated statement of income (loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00205 - Statement - Interim condensed consolidated statement of income (loss) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/StatementInterimCondensedConsolidatedStatementOfIncomeLossParenthetical</Role>
      <ShortName>Interim condensed consolidated statement of income (loss) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00300 - Statement - Interim condensed consolidated statement of comprehensive income (loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/StatementInterimCondensedConsolidatedStatementOfComprehensiveIncomeLoss</Role>
      <ShortName>Interim condensed consolidated statement of comprehensive income (loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00400 - Statement - Interim condensed consolidated statement of changes in shareholders' equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/StatementInterimCondensedConsolidatedStatementOfChangesInShareholdersEquity</Role>
      <ShortName>Interim condensed consolidated statement of changes in shareholders' equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00405 - Statement - Interim condensed consolidated statement of changes in shareholders' equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/StatementInterimCondensedConsolidatedStatementOfChangesInShareholdersEquityParenthetical</Role>
      <ShortName>Interim condensed consolidated statement of changes in shareholders' equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00500 - Statement - Interim condensed consolidated statement of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/StatementInterimCondensedConsolidatedStatementOfCashFlows</Role>
      <ShortName>Interim condensed consolidated statement of cash flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00505 - Statement - Interim condensed consolidated statement of cash flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/StatementInterimCondensedConsolidatedStatementOfCashFlowsParenthetical</Role>
      <ShortName>Interim condensed consolidated statement of cash flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10101 - Disclosure - Company information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureCompanyInformation</Role>
      <ShortName>Company information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>10201 - Disclosure - Basis of preparation and statement of compliance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureBasisOfPreparationAndStatementOfCompliance</Role>
      <ShortName>Basis of preparation and statement of compliance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>10301 - Disclosure - Accounting principles</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureAccountingPrinciples</Role>
      <ShortName>Accounting principles</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>10401 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPosition</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>10501 - Disclosure - Notes to the interim condensed consolidated statement of income (loss)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLoss</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>10601 - Disclosure - Other financial information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureOtherFinancialInformation</Role>
      <ShortName>Other financial information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>20302 - Disclosure - Accounting principles (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureAccountingPrinciplesPolicies</Role>
      <ShortName>Accounting principles (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureAccountingPrinciples</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>30203 - Disclosure - Basis of preparation and statement of compliance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureBasisOfPreparationAndStatementOfComplianceTables</Role>
      <ShortName>Basis of preparation and statement of compliance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureBasisOfPreparationAndStatementOfCompliance</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>30303 - Disclosure - Accounting Principles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureAccountingPrinciplesTables</Role>
      <ShortName>Accounting Principles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>30403 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPosition</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>30503 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLoss</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>30603 - Disclosure - Other financial information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureOtherFinancialInformationTables</Role>
      <ShortName>Other financial information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureOtherFinancialInformation</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>40101 - Disclosure - Company information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureCompanyInformationDetails</Role>
      <ShortName>Company information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureCompanyInformation</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>40102 - Disclosure - Company information - Combined transaction (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureCompanyInformationCombinedTransactionDetails</Role>
      <ShortName>Company information - Combined transaction (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>40103 - Disclosure - Company information - Debt Financing Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureCompanyInformationDebtFinancingTransactionsDetails</Role>
      <ShortName>Company information - Debt Financing Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Basis of preparation and statement of compliance - Significant investments in subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureBasisOfPreparationAndStatementOfComplianceSignificantInvestmentsInSubsidiariesDetails</Role>
      <ShortName>Basis of preparation and statement of compliance - Significant investments in subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>40202 - Disclosure - Basis of preparation and statement of compliance - Foreign exchange rates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureBasisOfPreparationAndStatementOfComplianceForeignExchangeRatesDetails</Role>
      <ShortName>Basis of preparation and statement of compliance - Foreign exchange rates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>40301 - Disclosure - Accounting principles - Fair value measurement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureAccountingPrinciplesFairValueMeasurementDetails</Role>
      <ShortName>Accounting principles - Fair value measurement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>40302 - Disclosure - Accounting principles - Going concern (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureAccountingPrinciplesGoingConcernDetails</Role>
      <ShortName>Accounting principles - Going concern (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>40401 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Intangible assets and Property, plant and equipment (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionIntangibleAssetsAndPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Intangible assets and Property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>40402 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Investments accounted for using the equity method (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionInvestmentsAccountedForUsingEquityMethodDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Investments accounted for using the equity method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>40403 - Disclosure - Notes to the unaudited interim condensed consolidated statement of (income) loss - Investment in Hepalys is accounted for using the equity method (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfIncomeLossInvestmentInHepalysIsAccountedForUsingEquityMethodDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of (income) loss - Investment in Hepalys is accounted for using the equity method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>40404 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Advances payments - non-current (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionAdvancesPaymentsNonCurrentDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Advances payments - non-current (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>40405 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Trade Receivables (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTradeReceivablesDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Trade Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>40406 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Tax receivables and Other current assets (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTaxReceivablesAndOtherCurrentAssetsDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Tax receivables and Other current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>40407 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Other (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionOtherDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>40408 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Cash and Cash equivalents balance from the statement of cash flows (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionCashAndCashEquivalentsBalanceFromStatementOfCashFlowsDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Cash and Cash equivalents balance from the statement of cash flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>40409 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Shareholders' Equity (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionShareholdersEquityDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Shareholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>40410 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Shareholders' equity - Changes in share capital (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionShareholdersEquityChangesInShareCapitalDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Shareholders' equity - Changes in share capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>40411 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Liquidity agreement (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionLiquidityAgreementDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Liquidity agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>40412 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Movements in BSPCE and BSA share warrants (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionMovementsInBspceAndBsaShareWarrantsDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Movements in BSPCE and BSA share warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>40413 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Movements in AGA (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionMovementsInAgaDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Movements in AGA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>40414 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Stock Options (SO) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionStockOptionsSoDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Stock Options (SO) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>40415 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Forward contract relating to the New EIB Warrants (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionForwardContractRelatingToNewEibWarrantsDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Forward contract relating to the New EIB Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>40416 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Debt, Derivatives and Royalty Certificates liabilities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionDebtDerivativesAndRoyaltyCertificatesLiabilitiesDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Debt, Derivatives and Royalty Certificates liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>40417 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Changes in liabilities arising from financing activities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionChangesInLiabilitiesArisingFromFinancingActivitiesDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Changes in liabilities arising from financing activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>40418 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - French state-guaranteed loan ("PGE") and equity recovery loans ("PPR") (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionFrenchStateGuaranteedLoanpgeAndEquityRecoveryLoanspprDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - French state-guaranteed loan ("PGE") and equity recovery loans ("PPR") (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>40419 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Credit facility agreement with the European Investment Bank (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionCreditFacilityAgreementWithEuropeanInvestmentBankDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Credit facility agreement with the European Investment Bank (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>40420 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Lease liabilities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionLeaseLiabilitiesDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>40421 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Long-term Derivatives (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionLongTermDerivativesDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Long-term Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>40422 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Long-term Derivatives - Warrants (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionLongTermDerivativesWarrantsDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Long-term Derivatives - Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>40423 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Short-term Derivative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionShortTermDerivativeDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Short-term Derivative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>40424 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Royalty Certificates liabilities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionRoyaltyCertificatesLiabilitiesDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Royalty Certificates liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>40425 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Provisions (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionProvisionsDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Provisions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>40426 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Net provision (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionNetProvisionDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Net provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>40427 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Changes in the net provision (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionChangesInNetProvisionDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Changes in the net provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>40428 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Breakdown of expense recognized for the period (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionBreakdownOfExpenseRecognizedForPeriodDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Breakdown of expense recognized for the period (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>40429 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Other current and non-current liabilities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionOtherCurrentAndNonCurrentLiabilitiesDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Other current and non-current liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>40430 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Additional information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionAdditionalInformationDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>40431 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Trade payables (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTradePayablesDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Trade payables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>40432 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Trade payables break down (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionTradePayablesBreakDownDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Trade payables break down (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>40433 - Disclosure - Notes to the unaudited interim condensed consolidated statement of financial position - Financial assets and liabilities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToUnauditedInterimCondensedConsolidatedStatementOfFinancialPositionFinancialAssetsAndLiabilitiesDetails</Role>
      <ShortName>Notes to the unaudited interim condensed consolidated statement of financial position - Financial assets and liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>40501 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) - Revenues and other income (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossRevenuesAndOtherIncomeDetails</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) - Revenues and other income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>40503 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) - Operating expenses (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossOperatingExpensesDetails</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) - Operating expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>40504 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) - Personnel costs and headcount (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossPersonnelCostsAndHeadcountDetails</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) - Personnel costs and headcount (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>40505 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) - Other operating income and expenses (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossOtherOperatingIncomeAndExpensesDetails</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) - Other operating income and expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>40506 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) - Additional Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossAdditionalInformationDetails</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>40507 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) - Financial income and expenses (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossFinancialIncomeAndExpensesDetails</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) - Financial income and expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>40508 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) - Share of net profit - Equity method (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossShareOfNetProfitEquityMethodDetails</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) - Share of net profit - Equity method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>40509 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) - Income tax (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossIncomeTaxDetails</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) - Income tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>40510 - Disclosure - Notes to the interim condensed consolidated statement of income (loss) - Basic and diluted loss per share (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossBasicAndDilutedLossPerShareDetails</Role>
      <ShortName>Notes to the interim condensed consolidated statement of income (loss) - Basic and diluted loss per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.inventivapharma.com/role/DisclosureNotesToInterimCondensedConsolidatedStatementOfIncomeLossTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Other financial information - Commitments given and received (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureOtherFinancialInformationCommitmentsGivenAndReceivedDetails</Role>
      <ShortName>Other financial information - Commitments given and received (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="iva-20260630xex99d1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>40602 - Disclosure - Other financial information - Financial risk management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.inventivapharma.com/role/DisclosureOtherFinancialInformationFinancialRiskManagementDetails</Role>
      <ShortName>Other financial information - Financial risk management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>iva-20260630.xsd</File>
    <File>iva-20260630_cal.xml</File>
    <File>iva-20260630_def.xml</File>
    <File>iva-20260630_lab.xml</File>
    <File>iva-20260630_pre.xml</File>
    <File doctype="EX-99.1" isDefinitelyFs="true" isIfrs="true" original="iva-20260630xex99d1.htm">iva-20260630xex99d1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>iva-20260630xex99d1001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="8">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="1107">https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
